| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 0T0250N43U |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Interferon lambda receptor agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis D | 3 | D003699 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Hepatitis C, Chronic | 3 | D019698 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Hepatitis, Chronic | 2 | D006521 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 914617-98-4 |
| ChEMBL | CHEMBL2108723 |
| FDA SRS | 0T0250N43U |
CONTENTS